45 related articles for article (PubMed ID: 31154837)
1. Effect of adjuvant chemotherapy on localized dedifferentiated low-grade osteosarcoma: a systematic review.
Tsukamoto S; Righi A; Mavrogenis AF; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Musculoskelet Surg; 2024 May; ():. PubMed ID: 38709428
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiated low-grade central osteosarcoma with extensive cystic change initially treated as a simple bone cyst.
Toya M; Yamada Y; Yokoyama R; Taguchi K; Nabeshima K; Isayama T; Oda Y
Pathol Res Pract; 2020 Apr; 216(4):152832. PubMed ID: 32057514
[TBL] [Abstract][Full Text] [Related]
3. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome.
Sheth DS; Yasko AW; Raymond AK; Ayala AG; Carrasco CH; Benjamin RS; Jaffe N; Murray JA
Cancer; 1996 Nov; 78(10):2136-45. PubMed ID: 8918422
[TBL] [Abstract][Full Text] [Related]
4. Parosteal osteosarcoma. A clinicopathological study.
Okada K; Frassica FJ; Sim FH; Beabout JW; Bond JR; Unni KK
J Bone Joint Surg Am; 1994 Mar; 76(3):366-78. PubMed ID: 8126042
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated Low-Grade Osteosarcoma, Outcome with or Without Chemotherapy: A Systematic Review.
Pacheco M; Guzmán R; Bonilla P
Orthop Res Rev; 2023; 15():79-89. PubMed ID: 37143718
[TBL] [Abstract][Full Text] [Related]
6. Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study.
Hirai T; Kobayashi H; Kobayashi E; Saito M; Akiyama T; Kikuta K; Nakai T; Endo M; Tsukamoto S; Hakozaki M; Takenaka S; Nishimura S; Kawashima H; Tanzawa Y; Kawano H; Tanaka S
Int J Clin Oncol; 2022 Nov; 27(11):1758-1766. PubMed ID: 35932377
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiated Low-Grade Central Osteosarcoma of the Mandible.
Yamagata K; Ishibashi-Kanno N; Matsuoka R; Uchida F; Fukuzawa S; Bukawa H
Case Rep Dent; 2022; 2022():9321728. PubMed ID: 35096429
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA Inhibits Osteosarcoma Growth through a Src Kinase-Dependent Mechanism.
Hu C; Zhu X; Zhang T; Deng Z; Xie Y; Yan F; Cai L
Evid Based Complement Alternat Med; 2021; 2021():5563691. PubMed ID: 34422073
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway.
Liu MY; Liu F; Li YJ; Yin JN; Gao YL; Wang XY; Yang C; Liu JG; Li HJ
Oxid Med Cell Longev; 2021; 2021():5040326. PubMed ID: 34257801
[TBL] [Abstract][Full Text] [Related]
10. Predictive Study of the Active Ingredients and Potential Targets of
Gong YB; Fu SJ; Wei ZR; Liu JG
Evid Based Complement Alternat Med; 2021; 2021():1480925. PubMed ID: 34194515
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG15 regulates osteosarcoma progression
Chen X; Xu H
Open Life Sci; 2020; 15(1):423-436. PubMed ID: 33817231
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of 91 H Suppresses the Tumorigenesis of Osteosarcoma via Inducing Methylation of CDK4 Promoter.
Cheng S; Zheng J; Liu X; Shi J; Gong F; Zhang X; Liu C; Liu C
Technol Cancer Res Treat; 2021; 20():1533033821990006. PubMed ID: 33499776
[TBL] [Abstract][Full Text] [Related]
13. Upregulated lncRNA THRIL/TNF-α Signals Promote Cell Growth and Predict Poor Clinical Outcomes of Osteosarcoma.
Xu B; Jin X; Yang T; Zhang Y; Liu S; Wu L; Ying H; Wang Z
Onco Targets Ther; 2020; 13():119-129. PubMed ID: 32021260
[TBL] [Abstract][Full Text] [Related]
14. miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2.
Guo J; Wu Q; Peng X; Yu B
Biomed Res Int; 2019; 2019():2523032. PubMed ID: 31930114
[TBL] [Abstract][Full Text] [Related]
15. A clinical comparison between dedifferentiated low-grade osteosarcoma and conventional osteosarcoma.
Toki S; Kobayashi E; Yoshida A; Ogura K; Wakai S; Yoshimoto S; Yonemori K; Kawai A
Bone Joint J; 2019 Jun; 101-B(6):745-752. PubMed ID: 31154837
[TBL] [Abstract][Full Text] [Related]
16. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.
Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
[TBL] [Abstract][Full Text] [Related]
18. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.
Bertoni F; Bacchini P; Staals EL; Davidovitz P
Cancer; 2005 Jun; 103(11):2373-82. PubMed ID: 15852358
[TBL] [Abstract][Full Text] [Related]
19. Dedifferentiated parosteal osteosarcoma of the maxilla: a case report and review of the literature.
Miyashita H; Yoshida K; Soma T; Kameyama K; Sasaki A; Hisaoka M; Yazawa M; Morioka H; Takahashi M; Nakagawa T; Kawana H
J Med Case Rep; 2018 Aug; 12(1):235. PubMed ID: 30115116
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
